Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Free Thinking: Behavioural economics

    March 27, 2015 |  

    Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

    Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.

    This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?

    Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM

    We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. 

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Summer Intern experience at Research Partnership

    We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research

    Double win at Communiqué 2016: Pegasus scoops awards for Consultancy of the Year (for the second time!) and Excellence in Media Relations

    Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have won the prestigious Consultancy of the Year award at the 2016 Communiqué Awards in London. The judges...

    Beyond Andrology: Trends in Men’s Health in Emerging Markets

    Published in eyeforpharma July 2016 by Rachel Howard

    Pharma & life sciences division growth allows Pegasus to fill three new senior positions

    Pegasus has expanded its pharma & life sciences senior team by appointing a new Associate Director and promoting two members of the existing team to Account Directors.

    Infographic: HIV Market Snapshot

    Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR (single...

    Infographic: The vaccine opportunity in Asia

    As predicted, the vaccine market in emerging and developing countries has continued to expand. While the global vaccine market is expected to grow at around 12% annually over the next...

    Webinar: What next for biosimilars?

    Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST

    Understanding the Patient Journey

    The patient journey is changing. Patients are now much more educated and engaged. They have access to information and want to be involved in decisions around their treatment programme.  Technology...

    Case Study: Oncology diagnostic biomarker landscaping study

    The challenge:Our client needed to understand moleculardiagnostic testing growth opportunities for a new biomarker in oncology. They wanted to understand the current market landscape, identify potential leverage points that would maximise use of the biomarker...

    Research Partnership publishes 2016 Living with RA reports

    Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.